Innovotech Inc. (TSXV: IOT) announced its intention to apply for a stock quotation on the OTCQB Venture Market, a US over-the-counter exchange, aiming to enhance its visibility among American investors and increase share liquidity. The move, disclosed on January 26, 2026, is designed to complement the company's primary listing on the TSX Venture Exchange without imposing additional material compliance burdens.
The OTCQB quotation, which operates alongside the Canadian listing, is expected to make Innovotech more accessible to retail and institutional investors in the United States. As a foreign private issuer, the company will continue to meet its disclosure obligations on SEDAR+, which satisfy OTC market requirements under established exemptions for foreign issuers. To qualify for the OTCQB, companies must meet certain financial standards, stay current in reporting, and undergo annual verification and management certification.
In conjunction with the OTCQB application, Innovotech will also seek eligibility with the Depository Trust Company (DTC), which would enable simplified electronic clearing and settlement of its common shares for US investors. This step is expected to further streamline trading for American shareholders.
Innovotech Inc. is a Canadian contract research organization specializing in advanced laboratory services and proprietary technologies, particularly in biofilm science. The company provides antimicrobial testing, pharmaceutical analysis, and industrial solutions, supported by its widely-used MBEC Assay® kit for high-throughput antimicrobial testing. Serving clients across multiple sectors, Innovotech operates ISO-certified and GMP-accredited laboratories that meet rigorous regulatory standards, including those of the US Food and Drug Administration and Health Canada. More information is available at https://www.innovotech.ca.
This announcement includes forward-looking statements subject to risks and uncertainties, such as regulatory outcomes, currency fluctuations, customer concentration, and intellectual property protection. Actual results may differ materially from those anticipated. The company undertakes no obligation to update such statements except as required by law. Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
